By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Johnson & Johnson 

1 Johnson & Johnson Plaza

New Brunswick  New Jersey  08933  U.S.A.
Phone: 732-524-0400 Fax: 732-524-3300


SEARCH JOBS


Industry
Pharmaceutical


Collaborations

Alliance Pharmaceutical Corp.  Oxygent ™ co-development

Medarex, Inc.  Broad HuMAb-Mouse antibody development agreement.

Incyte Corporation 

Genetronics, Inc.  On October 6, 1998 Genetronics entered into comprehensive development and license agreements involving its proprietary drug delivery system for Electroporation Therapy treatment of cancer with Ethicon, Inc., a Johnson & Johnson company

Essential Therapeutics, Inc.   Cephalosporin which is currently in pre-clinical stages - and will target Staphylococcal infections, Enterococcal infections, and Streptococcus pneumoniae infections.

Pharmagene Laboratories Limited 

Bristol-Myers Squibb Company 

Amersham Biosciences 

PanVera LLC 

Rigel Pharmaceuticals, Inc. 

Massachusetts Life Sciences Center 





Company News
Amgen (AMGN), AstraZeneca PLC (AZN)'s Brodalumab Phase 3 Study Met All Primary Endpoints Against Johnson & Johnson (JNJ)'s Stelara 11/26/2014 5:55:16 AM
Johnson & Johnson (JNJ) Demands $7.2 Billion From Boston Scientific Corporation (BSX) As Trial Begins 11/21/2014 5:48:24 AM
Johnson & Johnson (JNJ) Partners With Save The Children To Help Millions Of Children Over The Next Three Years 11/20/2014 11:56:11 AM
Johnson & Johnson (JNJ) Wants $5 Billion From Boston Scientific Corporation (BSX) For Guidant Corporation (GDT) Jilting 11/19/2014 8:07:10 AM
Mallinckrodt Pharmaceuticals (MNK)'s Generic ADHD Drug Does Not Measure Up To Johnson & Johnson (JNJ)'s Concerta: FDA 11/14/2014 6:10:49 AM
Geron Corporation (GERN) Signs Top Drug Over To Johnson & Johnson (JNJ) In Deal Worth $935 Million 11/14/2014 5:54:20 AM
Amgen (AMGN) And AstraZeneca PLC (AZN)'s Psoriasis Drug Tops Johnson & Johnson (JNJ)'s Stelara In Phase 3 Study 11/12/2014 6:07:17 AM
Drugmakers Like Johnson & Johnson (JNJ), Emergent BioSolutions (EBS), And Mapp Biopharmaceutical Stand To Gain Ebola Contracts Worth $2 Billion 11/11/2014 6:48:25 AM
Johnson & Johnson (JNJ) Announces Completion Of Alios BioPharma Acquisition 11/10/2014 8:00:38 AM
Johnson & Johnson (JNJ) Chief Eyes Acquisitions In China 11/10/2014 6:24:42 AM
12345678910...
//-->